EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lactoferrin—A Regulator of Iron Homeostasis and Its Implications in Cancer

Izabela Bolesławska iD, Natasza Bolesławska-Król, Karol Jakubowski, Juliusz Przysławski iD, Sławomira Drzymała-Czyż iD

Molecules · 2025

DOI: 10.3390/molecules30071507 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Izabela Bolesławska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bromatology, Poznan University of Medical Sciences, 60-806 Poznan, Poland. Hauptthemen laut MEDLINE: Lactoferrin, Neoplasms, Iron, Homeostasis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a global health challenge, and its development is closely linked to iron metabolism. Cancer cells have an increased demand for this element, which promotes their proliferation, invasion, and metastasis. Excess iron catalyzes the formation of reactive oxygen species (ROS), which can both induce ferroptosis and initiate oncogenic signaling pathways. The deregulation of iron metabolism in cancer patients leads to anemia or toxic iron overload and also affects the gut microbiota. Lactoferrin (LF), a glycoprotein with strong iron chelating properties, can regulate its availability to cancer cells, thereby limiting their growth and progression. By chelating free Fe ions, LF reduces oxidative stress and inhibits the mechanisms that promote carcinogenesis. Additionally, it exhibits immunomodulatory and anti-inflammatory effects and may enhance the body’s anti-tumor response. This review analyses the mechanisms of action of lactoferrin in the context of cancer, with a particular focus on its chelating, antioxidant, and immunomodulatory properties. The multidirectional effects of LF make it a promising component of preventive and therapeutic strategies, requiring further clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LactoferrinNeoplasmsIronHomeostasisHumansAnimalsReactive Oxygen SpeciesOxidative Stress

Stichwörter der Autor:innen

anemia resulting from canceranti-inflammatory effectsanticancerantioxidanteffects on the microbiomeironlactoferrin

Substanzen

LactoferrinIronReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Bromatology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.
  • Student Society of Radiotherapy, Collegium Medicum, University of Zielona Góra, Zyta 28, 65-046 Zielona Góra, Poland.

ORCID-Profile: Izabela Bolesławska, Juliusz Przysławski, Sławomira Drzymała-Czyż

Zitieren

APA

Bolesławska, I., Bolesławska-Król, N., Jakubowski, K., Przysławski, J., & Drzymała-Czyż, S. (2025). Lactoferrin—A Regulator of Iron Homeostasis and Its Implications in Cancer. Molecules. https://doi.org/10.3390/molecules30071507

Vancouver

Bolesławska I, Bolesławska-Król N, Jakubowski K, Przysławski J, Drzymała-Czyż S. Lactoferrin—A Regulator of Iron Homeostasis and Its Implications in Cancer. Molecules. 2025. doi:10.3390/molecules30071507

BibTeX
@article{Bolesawska2025,
  author = {Bolesławska, Izabela and Bolesławska-Król, Natasza and Jakubowski, Karol and Przysławski, Juliusz and Drzymała-Czyż, Sławomira},
  title = {Lactoferrin—A Regulator of Iron Homeostasis and Its Implications in Cancer},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30071507}
}
Kostenlos starten →